EBO Stock Overview
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for EBO from our risk checks.
My Notes
NewNotes are coming soon
EBOS Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$44.57 |
| 52 Week High | NZ$46.50 |
| 52 Week Low | NZ$35.50 |
| Beta | 0.40 |
| 1 Month Change | 1.53% |
| 3 Month Change | 18.41% |
| 1 Year Change | 14.58% |
| 3 Year Change | 91.29% |
| 5 Year Change | 150.53% |
| Change since IPO | 1,864.00% |
Recent News & Updates
A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)
Jan 06
EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively
Nov 28Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns
Oct 21EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate
Oct 05Recent updates
A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)
Jan 06EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively
Nov 28Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns
Oct 21EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate
Oct 05Does EBOS Group (NZSE:EBO) Have A Healthy Balance Sheet?
Sep 13EBOS Group (NZSE:EBO) Will Pay A Larger Dividend Than Last Year At A$0.5116
Aug 26Slowing Rates Of Return At EBOS Group (NZSE:EBO) Leave Little Room For Excitement
Jun 24An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 30% Undervalued
May 10Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing
Mar 17We Think That There Are Issues Underlying EBOS Group's (NZSE:EBO) Earnings
Feb 26EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year
Feb 18EBOS Group Limited's (NZSE:EBO) Intrinsic Value Is Potentially 41% Above Its Share Price
Jan 22Is EBOS Group (NZSE:EBO) Using Too Much Debt?
Dec 26EBOS Group (NZSE:EBO) Has Some Way To Go To Become A Multi-Bagger
Oct 31An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 23% Undervalued
Oct 18Is EBOS Group (NZSE:EBO) A Risky Investment?
Sep 19Here's Why I Think EBOS Group (NZSE:EBO) Might Deserve Your Attention Today
Aug 05A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)
Jul 13EBOS Group's (NZSE:EBO) Returns Have Hit A Wall
Jun 09Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?
May 01Here's Why EBOS Group (NZSE:EBO) Can Manage Its Debt Responsibly
Apr 08A Look At The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)
Mar 27Is EBOS Group Limited's (NZSE:EBO) Recent Performance Tethered To Its Attractive Financial Prospects?
Mar 15Is EBOS Group Limited (NZSE:EBO) A Smart Pick For Income Investors?
Mar 03Analysts Are Updating Their EBOS Group Limited (NZSE:EBO) Estimates After Its Half-Year Results
Feb 19
Has EBOS Group (NZSE:EBO) Got What It Takes To Become A Multi-Bagger?
Feb 09With EPS Growth And More, EBOS Group (NZSE:EBO) Is Interesting
Jan 27EBOS Group (NZSE:EBO) Has Gifted Shareholders With A Fantastic 147% Total Return On Their Investment
Jan 14Estimating The Fair Value Of EBOS Group Limited (NZSE:EBO)
Dec 26EBOS Group Limited's (NZSE:EBO) Stock Has Fared Decently: Is the Market Following Strong Financials?
Dec 14Is EBOS Group Limited (NZSE:EBO) A Good Fit For Your Dividend Portfolio?
Dec 02Could The EBOS Group Limited (NZSE:EBO) Ownership Structure Tell Us Something Useful?
Nov 20Shareholder Returns
| EBO | NZ Healthcare | NZ Market | |
|---|---|---|---|
| 7D | -2.5% | 5.1% | 0.5% |
| 1Y | 14.6% | -8.6% | -4.1% |
Return vs Industry: EBO exceeded the NZ Healthcare industry which returned -8.6% over the past year.
Return vs Market: EBO exceeded the NZ Market which returned -4.1% over the past year.
Price Volatility
| EBO volatility | |
|---|---|
| EBO Average Weekly Movement | 3.5% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in NZ Market | 7.3% |
| 10% least volatile stocks in NZ Market | 2.6% |
Stable Share Price: EBO is not significantly more volatile than the rest of NZ stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: EBO's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1922 | 5,000 | John Cullity | https://www.ebosgroup.com |
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and internationally. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services.
EBOS Group Limited Fundamentals Summary
| EBO fundamental statistics | |
|---|---|
| Market Cap | NZ$8.62b |
| Earnings (TTM) | NZ$221.22m |
| Revenue (TTM) | NZ$11.72b |
38.4x
P/E Ratio0.7x
P/S RatioIs EBO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EBO income statement (TTM) | |
|---|---|
| Revenue | AU$10.73b |
| Cost of Revenue | AU$9.50b |
| Gross Profit | AU$1.23b |
| Other Expenses | AU$1.03b |
| Earnings | AU$202.61m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Feb 21, 2023
| Earnings per share (EPS) | 1.06 |
| Gross Margin | 11.49% |
| Net Profit Margin | 1.89% |
| Debt/Equity Ratio | 64.0% |
How did EBO perform over the long term?
See historical performance and comparison